Warren Buffett’s $7.8b pharma bet – The Australian Financial Review

The four new purchases more than doubled the size of Berkshires investments in healthcare stocks in the third quarter to $US9.3 billion in total. The company already held stakes in the drugmakers Biogen, Johnson & Johnson and Teva Pharmaceuticals and DaVita, a kidney dialysis company.
Mr Buffett did not respond to a request for comment.
Berkshire cut its stake in several large banks during the three months to the end of September, including Wells Fargo, JPMorgan Chase, PNC Financial and M&T Bank….

Click here to view the original article.